Peter Nawroth
Overview
Explore the profile of Peter Nawroth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
3006
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Han Z, Madhavan B, Kaymak S, Nawroth P, Kumar V
Bio Protoc
. 2022 Dec;
12(16).
PMID: 36505273
Stable cell cloning is an essential aspect of biological research. All advanced genome editing tools rely heavily on stable, pure, single cell-derived clones of genetically engineered cells. For years, researchers...
12.
Mooshage C, Schimpfle L, Kender Z, Szendroedi J, Heiland S, Nawroth P, et al.
Diabetes
. 2022 Nov;
72(2):290-298.
PMID: 36326808
Clinical studies investigating the benefit of glucose control on the progression of diabetic neuropathy (DN) have come to controversial results in patients with type 2 diabetes (T2D). This study aimed...
13.
Krishnan S, Manoharan J, Wang H, Gupta D, Fatima S, Yu Y, et al.
Kidney Int
. 2022 Oct;
103(2):304-319.
PMID: 36309126
Dysfunction of mesangial cells plays a major role in the pathogenesis of diabetic kidney disease (DKD), the leading cause of kidney failure. However, the underlying molecular mechanisms are incompletely understood....
14.
Al-Saoudi E, Christensen M, Nawroth P, Fleming T, Hommel E, Jorgensen M, et al.
Front Endocrinol (Lausanne)
. 2022 Oct;
13:891442.
PMID: 36303871
Aims/hypothesis: Advanced glycation end-products (AGEs) may contribute to the development of diabetic neuropathy. In young adults with type 1 diabetes, we aimed to investigate the association between AGEs and cardiovascular...
15.
Garcia M, Meissburger B, Chan J, de Guia R, Mattijssen F, Roessler S, et al.
Adv Sci (Weinh)
. 2022 Aug;
9(29):e2104291.
PMID: 36031387
Aberrant energy metabolism and cell cycle regulation both critically contribute to malignant cell growth and both processes represent targets for anticancer therapy. It is shown here that depletion of the...
16.
Jende J, Mooshage C, Kender Z, Schimpfle L, Juerchott A, Nawroth P, et al.
Front Endocrinol (Lausanne)
. 2022 May;
13:839774.
PMID: 35620394
Objective: The pathogenesis of diabetic polyneuropathy (DN) is poorly understood and given the increasing prevalence of DN, there is a need for clinical or imaging biomarkers that quantify structural and...
17.
Jende J, Mooshage C, Kender Z, Schimpfle L, Juerchott A, Heiland S, et al.
Ann Clin Transl Neurol
. 2022 Apr;
9(6):830-840.
PMID: 35488789
Objectives: Clinical and histological studies have found evidence that nerve ischemia is a major contributor to diabetic neuropathy (DN) in type 2 diabetes (T2D). The aim of this study was...
18.
Wolff G, Sakurai M, Mhamane A, Troullinaki M, Maida A, Deligiannis I, et al.
Mol Metab
. 2022 Apr;
60:101487.
PMID: 35378329
Objective: Fibrotic organ responses have recently been identified as long-term complications in diabetes. Indeed, insulin resistance and aberrant hepatic lipid accumulation represent driving features of progressive non-alcoholic fatty liver disease...
19.
Monzer N, Hartmann M, Buckert M, Wolff K, Nawroth P, Kopf S, et al.
PLoS One
. 2022 Mar;
17(3):e0265234.
PMID: 35303015
Background: Impaired cardiac autonomic control is common among people with type 2 diabetes. The autonomic nervous system and its regulatory influence on the cardiovascular system also play a key role...
20.
Jende J, Mooshage C, Kender Z, Kopf S, Groener J, Heiland S, et al.
Front Neurosci
. 2022 Mar;
15:811085.
PMID: 35242003
Objective: It is controversially discussed in how far smoking contributes to diabetic polyneuropathy (DPN) in type 2 diabetes (T2D). Diffusion-weighted magnetic resonance neurography (MRN) at 3 Tesla has been shown...